Vico
PrivateLast Round
Series B
Extension
Jun 24, 2024
Total Funding Raised
$103.4M
Company Overview
Vico Therapeutics is a biotechnology company that develops modulating therapies aimed at treating patients with severe neurological disorders, with an initial focus on spinocerebellar ataxia and other rare neurodegenerative and neurodevelopmental conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vico Comps
Public and private peers based on sector, stage, and business model.
Vico Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 24, 2024 | ||||
| Series B | Jan 5, 2024 | ||||
| Series A | Jul 29, 2020 |
Vico Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kurma Biofund | Series B Extension |
| Ackermans & van Haaren | Series B Extension, Series B |
| EQT Life Sciences | Series B Extension, Series A, Series B |
| Idinvest Partners | Series A |
| Seroba Life Sciences | Series B Extension |
| Pontifax Credit | Series A |
| Droia Ventures | Series B Extension, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Product candidate VO659 is undergoing a first-in-human study for rare neurological disorders.
- Jun 22, 2025
Job posting indicates preparation for IPO as part of growth strategy.
Vico Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vico's valuation, stock price, and market status.
